Promyelocytic leukemia (PML) proteins have been implicated in antiviral responses but PML and 25 associated proteins are also suggested to support virus replication. One isoform, PML-II, is required 26 for efficient transcription of interferon and interferon-responsive genes. . We therefore investigated 27 the PML-II contribution to human adenovirus 5 (Ad5) infection, using shRNA-mediated knock-down. 28
Removal of PML-II increases the productivity of Ad5 infection. To establish the effect of PML-II on 104
Ad5 infection, HelaΔII and HelaEV cells were infected in parallel with wild-type (wt) Ad5. Looking at 105 protein expression over a time course, there was a strikingly higher level of late protein expression in 106
HelaΔII cells (Fig. 2a) ; with an exposure selected to avoid grossly overexposing the HelaΔII lane, late 107 proteins in the HelaEV cells were barely detectable. In contrast, expression of the early protein E2A 108 72K DNA binding protein (DBP) was much less affected by the removal of PML-II though the E1B 55K 109 protein was, by the late stage of infection (24 h p.i.), significantly increased (Fig. 2a) . The expression 110 of late proteins in HelaEV cells was similar to that in untransduced standard Hela cells (Fig 2b) , 111 confirming that the difference between HelaΔII and HelaEV infections was not due to any 112 unexpected negative effect of introducing the retroviral vector alone in HelaEV cells. The effect of 113 PML-II depletion on viral gene expression was confirmed and quantified by flow cytometry (Fig. 2c) from HelaEV cells (Fig 3a, b) increased Ad5 wt300 late gene expression by a modest amount (Fig. 3c) we asked whether this interaction also inhibited the natural IFN response to Ad5 infection. To 137 determine whether viral expression of E4 Orf3 had any measurable effect on induction of type 1 IFN 138 during infection, culture media from Ad5-infected HEK293 cells (Fig. 4a) or MRC5 normal human 139 fibroblasts (Fig. 4b) were tested in plaque reduction assays using Semliki Forest virus, an IFN-140 sensitive alphavirus. In both cell types, IFN activity was detected from an Orf3-deficient virus 141 infection (inOrf3) while none was detected from wt300 or mock infections. Based on a calibration of 142 the assay with recombinant IFNα, which showed inhibition from 0% to 100% by IFN in the range 0.1 143 -100 U/ml, inOrf3medium contained ~50 U/ml IFN. In separate experiments, IFN levels in infected 144 HEK293 cell culture media were determined using an IFN-responsive reporter assay (Chen et al., 145 2015) . Again, IFN accumulation was detected only in inOrf3-infected cultures ( IIΔRBCC and further reduced reporter activity to levels below that of poly(I:C) stimulation in the 155 absence of exogenous PML (Fig. 4d) . This reduction below baseline reflected the contribution of 156 endogenous PML-II, also an E4 Orf3 target, to the observed IFNβ promoter activation as, in the 157 presence only of endogenous PML, added Orf3 also gave a dose-dependent inhibition of poly(I:C)-158 stimulated reporter activity (Fig. 4e) . 159
To correlate the activity of E4 Orf3 in regulating IFNβ expression with its ability to bind PML-II, we 160 compared the inhibitory effect of wild-type E4 Orf3 with that of selected Orf3 mutants (Hoppe et al., 161 2006) . Those mutants unable to bind PML-II (N82A, L103A) also failed to inhibit activation of the 162
IFNβ promoter while mutants that retained PML-II binding (R100A, D105-L106A) had inhibitory 163 activity similar to wild-type ( Fig. 4e-i) . Importantly, mutant D105-L106A uniquely retains PML-NB 164 rearrangement activity whilst lacking the ability to disrupt the location of the MRN protein complex 165 The inhibitory effect of E4 Orf3 on PML-II function suggested that an Orf3-deficient virus should 168 benefit more from the lack of PML-II in HelaΔII cells than a virus that was able to make Orf3. When 169 wt300 and inOrf3 late protein expression was compared in HelaEV cells (Fig. 5, lanes 2, 4) , amounts 170 were very similar, as expected (Huang & Hearing, 1989) . As also shown previously, in Vero cells and 171 human fibroblasts (Ullman et al., 2007) , IFNα pre-treatment more severely inhibited inOrf3 than 172 wt300 late protein synthesis in HelaEV cells (Fig. 5, lanes 3, 5) . Importantly, removal of PML-II in 173
HelaΔII cells largely abolished this difference in viral gene expression (Fig. 5, lanes 8, 10) , confirming 174 that PML-II is a significant functional target of E4 Orf3 during infection. However, contrary to 175 expectation, wt300 gene expression benefitted more than that of mutant virus inOrf3 from PML-II 176 removal (Fig. 5, lanes 2, 7 and 4, 9 ), see below. Collectively, our results show that PML-II is inhibitory 177 to Ad5 infection in part through its role in the development of an IFN response and that E4 Orf3 178 inhibits this function of PML-II. 179
Enhanced growth of Ad5 in HelaΔII cells reflects overexpression of HSP70. A significant part of the 180 benefit to Ad5 of PML-II depletion was independent of IRF3 and hence was not directly related to 181 the IFN response (Fig. 3) . Hence, late protein expression by either wt300 or inOrf3 was greater in 182
HelaΔII cells than in equivalently treated HelaEV cells (Fig. 5 ). An early observation we made during 183 characterization of HelaΔII cells was that they displayed elevated levels of HSP70 mRNA in 184 comparison with standard Hela cells and various control cells, including HelaEV (Fig. 6a) . HSP70 was 185 also induced to a lower level by transient knock-down of PML-II (Fig. 6b) , suggesting a direct link 186 between loss of PML-II and HSP70 expression. Ad5 infection also induces HSP70 expression (Nevins, 187 1982) and, since it inhibits many other host genes whose activity is detrimental to infection (Zhao et (Fig. 7d) . These data indicate that NF-κB signalling increases rather than 233 inhibits Ad5 gene expression in our system and that HSP70 limits rather than increases this effect. 234
The beneficial effect on Ad5 infection of the high levels of HSP70 in HelaΔII cells must therefore be 235 due to some other function of HSP70. 236 HSP70's principal role is as a chaperone: during heat-stress it stabilises partially denatured proteins 237 to prevent aggregation and facilitate re-folding (Clerico et al., 2015) . The Ad5 replication cycle 238 involves both the disassembly and assembly of protein complexes, processes which might be 239 facilitated by HSP70. Indeed, HSP70 interacts both with the hexon shell of Ad2 particles shortly after 240 infection (Niewiarowska et al., 1992) and with fibre protein during the late phase of Ad5 infection 241 (Macejak & Luftig, 1991), and has been implicated in uncoating and import of the genome into the 242 nucleus (Saphire et al., 2000) . We therefore examined whether increased HSP70 present in HelaΔII 243 cells altered the subcellular location of hexon protein, as an indicator of possible effects on particle 244 assembly. Prior depletion of hsp70 from these cells, as well as decreasing the overall level of hexon 245 protein as already described, increased more than two-fold the cytoplasmic / nuclear ratio of hexon 246 ( Fig. 8a ; quantitation under right panels) whereas it had little effect on the distribution of E1A or E2A 247 DBP. This result suggests that HSP70 overexpression consequent on PML-II depletion may positively 248 affect the assembly of progeny particles in the nuclear compartment and hence could contribute to 249 the increased yield of virus. 250
Any impact of HSP70 level on assembly cannot explain the effect of HSP70 on hexon mRNA levels 251 (Fig. 6 ). This mRNA is produced by processing of transcripts from the major late promoter (MLP), 252 which itself is positively influenced by L4-22K protein expressed from L4P which is activated at the 253 onset of the late phase (Morris et al., 2010) . We therefore tested the effect of HSP70 depletion on 254 the activity of MLP and L4P luciferase reporters in Hela cells (Fig. 8b) , but found that neither was 255 significantly affected. Thus HSP70 does not increase directly the intrinsic activity of either promoter 256 when taken out of the context of viral infection and must therefore affect late gene expression post-257 transcriptionally or dependent on the infected cell environment. In this regard, the increase in E1B 258 55K protein upon PML-II depletion (Fig. 2a) , which is known to positively regulate late mRNA nucleo-259 cytoplasmic transport and accumulation (Leppard, 1998), was notable. HSP70 depletion in HelaΔII 260 cells reversed this increase (Fig. 8a) , further suggesting that it could be significant in the elevation of 261 late gene expression. HSP70 is also induced during Ad5 infection (Nevins, 1982) and, whilst virus infection might be 343 considered a stress that would lead to generalized activation of HSP expression, this induction is 344 actually specific to HSP70 (Phillips et al., 1991) . These studies did not distinguish between HSPA1A 345 and HSPA1B, which were not separately recognised at the time. (White et al., 1988) . HSP70 was recruited from 361 the cytoplasm into discrete nuclear structures that co-localized with E1A and which appeared similar 362 to the reorganized PML tracks that are formed by E4 Orf3 (Carvalho et al., 1995; Doucas et al., 1996) . 363
Indeed, Carvalho et al. found a small fraction of E1A and, in a few infected cells, HSP70 located in 364 these Orf3 / PML structures, evidence of a physical and/or functional link between HSP70 and PML 365 that might be related to our observations. Interestingly, our work suggests that the presence of E4 366
Orf3 is required in order for Ad5 to benefit from the elevation of HSP70 that occurs in HelaΔII cells. In conclusion, we have shown that PML-II opposes productive Ad5 infection, in part by supporting 378 innate immune responses but mainly due to a suppressive effect on HSP70 expression. Our study 379 reveals a previously undefined activity for HSP70 in supporting Ad5 late gene expression and 380
demonstrates an inhibitory effect of PML-II on HSP70 expression. 381
Materials and Methods 382

Generation of HelaΔII and HelaEV cell lines 383
Hela cells were transduced with either lentiviral particles encoding an shRNA specific for PML-II or 384 equivalent particles with no shRNA insert. The PML-II shRNA incorporated the active siRNA sequence 385 described by (Kumar et al., 2007) which was used previously by our laboratory to achieve functional 386 knock-down of PML-II (Chen et al., 2015) . Lentiviral particles were generated using pLKO.1 (Moffat et 387 al., 2006) following protocols supplied by the RNAi consortium (Addgene). Briefly, a double-stranded 388 synthetic oligonucleotide corresponding to the shRNA was cloned into pLKO.1. Specific plasmid 389 clones were verified by sequencing, then transfected with psPAX2 and pMD2.G packaging plasmids 390 into HEK-293T cells using Transit LT-1 (Mirus) to produce VSV-G-pseudotyped particles. Particle 391 stocks were then used to infect Hela cells and transduced cells were selected with 3 µg/ml 392 puromycin. 393
Antibodies and reagents 394
Specific primary antibodies were: AdJLB1 rabbit antiserum to Ad5 late proteins (Farley et al., 2004) ; 395 mouse monoclonal antibodies 2HX-2 to Ad5 hexon (Cepko et al., 1983) , B6-8 to Ad5 E2A DNA 396 binding protein (DBP) (Reich et al., 1983) , and 2A6 to Ad5 E1B 55K (Sarnow et al., 1982) ; 397 monospecific anti-peptide sera reactive against PML-II (Xu et al., 2005) 
